These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20560023)

  • 1. Preconditioning and stem cell survival.
    Haider HKh; Ashraf M
    J Cardiovasc Transl Res; 2010 Apr; 3(2):89-102. PubMed ID: 20560023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
    Jackson R; Tilokee EL; Latham N; Mount S; Rafatian G; Strydhorst J; Ye B; Boodhwani M; Chan V; Ruel M; Ruddy TD; Suuronen EJ; Stewart DJ; Davis DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002104. PubMed ID: 26363004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning of stem cells for the treatment of myocardial infarction.
    Lu HH; Li YF; Sheng ZQ; Wang Y
    Chin Med J (Engl); 2012 Jan; 125(2):378-84. PubMed ID: 22340575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways.
    Teng L; Bennett E; Cai C
    J Biol Chem; 2016 Apr; 291(18):9733-47. PubMed ID: 26940876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.
    Raziyeva K; Smagulova A; Kim Y; Smagul S; Nurkesh A; Saparov A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK/STAT signaling.
    Yadav M; Kumari P; Yadav V; Kumar S
    Heart Fail Rev; 2020 Mar; 25(2):355-366. PubMed ID: 31309353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction].
    Maslov LN; Podoksenov IuK; Portnichenko AG; Naumova AV
    Vestn Ross Akad Med Nauk; 2013; (12):16-25. PubMed ID: 24741938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.
    Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC
    Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
    Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.
    Kim HW; Haider HK; Jiang S; Ashraf M
    J Biol Chem; 2009 Nov; 284(48):33161-8. PubMed ID: 19721136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling.
    Uemura R; Xu M; Ahmad N; Ashraf M
    Circ Res; 2006 Jun; 98(11):1414-21. PubMed ID: 16690882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning approach in stem cell therapy for the treatment of infarcted heart.
    Haider KH; Ashraf M
    Prog Mol Biol Transl Sci; 2012; 111():323-56. PubMed ID: 22917238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell therapy for chronic myocardial infarction.
    Mazo M; Pelacho B; Prósper F
    J Cardiovasc Transl Res; 2010 Apr; 3(2):79-88. PubMed ID: 20560022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
    Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell death and survival in heart regeneration and repair.
    Abdelwahid E; Kalvelyte A; Stulpinas A; de Carvalho KA; Guarita-Souza LC; Foldes G
    Apoptosis; 2016 Mar; 21(3):252-68. PubMed ID: 26687129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Assays Using Cardiac Stem Cells.
    Rosdah AA; Delbridge LMD; Lim SY
    Methods Mol Biol; 2019; 2029():175-183. PubMed ID: 31273742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium.
    Wang QL; Wang HJ; Li ZH; Wang YL; Wu XP; Tan YZ
    J Cell Mol Med; 2017 Sep; 21(9):1751-1766. PubMed ID: 28244640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.
    Haider HKh; Ashraf M
    J Mol Cell Cardiol; 2008 Oct; 45(4):554-66. PubMed ID: 18561945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats.
    Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ
    Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.